Your browser is old and is not supported. Upgrade for better security.

Invest in itracHEALTH

eNURSE, the smart personal health assistant for at risk patients living at home



raised from 41 investors
 $15M  $14M valuation cap Future Equity
Early Bird Bonus: The first $300K of investments will be in a SAFE with a $14M valuation cap and 20% discount
$500, $1K, $5K, $10K
Stephen Wasserman
itracHealth has developed a product offering addressing the needs of the market (both users and physicians) at a price point that should provide excellent returns for the Company, customers and Medicare. The market is well defined, sizeable and reachable. Management has proven experience with medical devices, grown companies significantly and delivered outstanding returns to shareholders. Lastly, the product, eNurse, is ready for submission to the FDA for approval.


eNURSE can revolutionize chronic care at home assisting patients, caregivers & medical professionals
A fully integrated product platform ready to initiate FDA clearance process and commercialization
Founders- serial entrepreneurs that increased the market cap of prior venture from $35MM to $400MM
A team with a track record of successful commercial execution in the medical devices business.
A B2B2C product launch plan - initial target: group practices. Established Medicare reimbursements
Subscription based model with multiple revenue streams & gross margins over 70% (not guaranteed)
Founders and friends have invested their own money to fund the company thus far.
Patented technology - eNURSE Plus has several US and International patents issued.

Our Team

Based on our personal experience assisting my mother-in-law remotely, my wife and I realized that there are four major problems that have not been effectively addressed by today's technological solutions to make a major impact in patient outcomes, cost and patient satisfaction: 1. the lack of technology-based, highly integrated solutions to assist self-managed patients living at home with their complex chronic care protocols. 2. The need for a single-point solution that can concurrently support the three principal actors in chronic care management at home: patient, physician and caregiver. 3. Medication management requires much more than pill dispensing because at-risk and frail patients frequently require medication changes or a variable medication regimen. Medication management is the biggest challenge at home, but all home healthcare protocols are important. The eNURSE Smart Medication Modules resolves this, 4. Physicians are extremely busy and need reliable, real time contextual information (not raw data) to personalize care and coordinate chronic care services.

eNURSE enables chronic care at home and everywhere:

Chronic care management at home is complex and burdensome, and affects three principals users: patients, their medical professionals and caregivers.

Market research indicates that effective chronic care management at home requires much more than dispensing pills or checking vital signs, only. It requires addressing the aggregate effect of most home healthcare protocols, social determinants of health and other indicators of patient health status, because they significantly affect the patient´s ability to comply with their daily health regimen.

Our "electronic nurse" assists patients, caregivers and medical professionals addressing the aggregate effect of many home healthcare challenges and enabling proactive and personalized care. Busy physicians value home health information-not raw data.

Our systems are anchored in medication management (a patient´s biggest challenge), but itracHEALTH provides comprehensive functionality to support most healthcare protocols

of at-risk and frail patients living at home.

eNURSE AI capabilities make most technical complexities invisible to the users. We use proprietary and cybersecure communication protocols to achieve high reliability, ease of use and privacy.

The eNURSE emulates a real nurse at home and away from home, 24x7. It´s a One Stop Solution for Chronic Care at Home. Automation and real-time patient generated home health information add new dimensions to home healthcare providing reliable daily health data instead of the traditional spot check at a doctor´s office.

The eNURSE is a finalist for the prestigious 2023 International Design Excellence Award (IDEA) in the Medical & Health category, and has been invited by the Industrial Designers Society of America to participate in the final competition in June 2023.

Both products provide the same holistic functionality, but the eNURSE PLUS has the higher level of automation, safety and security needed by frail patients.

To our knowledge, there is no system in the market or in development with the comprehensive capabilities and ease of use of our eNURSE platform. There are many remote patient monitoring integrators, but remote patient monitoring-only solutions are not perceived to provide an immediate personal benefit, by the patient-user.

The healthcare market trends, and consumer preferences are in our favor. The home has become an extension of the hospital, but little has been done to assist patients with the increasing complexity of their home healthcare regimen.

Our product addresses the needs of many market segments and geographies, some of which are not included in our financial projections. These additional market opportunities could result in incremental revenue and profits, beyond our initial market projections. Partnerships will be pursued to benefit from distribution synergies and access.

A recurring revenue model with multiple revenue streams – RPM (remote patient monitoring, RTM (remote therapeutic monitoring), and RCC (remote chronic care monitoring).

Forward-looking projections are not guaranteed.

The deployment of eNURSE should increase the physician´s office operational efficiencies, profits and reputation. A successful implementation of an RPM strategy is projected to produce $40K of incremental profit per physician.

Forward-looking projections are not guaranteed.

A staged launch plan in line with funding, profitability targets and scalability considerations. The business model is scalable to other market segments and geographies with incremental funding. International sales are not included.

Forward-looking projections are not guaranteed.

Use of Proceeds. eNURSE is essentially complete. Proceeds from this fundraiser will be used for FDA clearance and initial commercial activities

A three-state hubs launch plan benefiting from the compounding effect of the subscription revenue, net of churn rates.

Forward-looking projections are not guaranteed. Contingent on funding.

Forward-looking projections are not guaranteed. Contingent on funding.

A management team with a track record of successful healthcare product launches, excellent commercial execution and vast regulatory experience dealing with FDA, ISO/ CE and other regulatory agencies. The commercial team has a deep understanding of "solutions selling" to healthcare institutions.

Our advisory board is composed by a seasoned team of gerontologists, senior care experts and practicing geriatricians supplemented by a team of pharmacists, psychologists and user-experience experts with decades of experience in chronic care at home.